Mike graduated from the University of Sheffield in the UK with a degree in Genetics. After an MSc in Applied Genetics; he completed his doctorate at the University of Birmingham.
Mike has worked in clinical development for over 25 years at Hoechst and Pfizer.
He is currently Head of Global Clinical Operations at Alexion.
Mike is passionate about meeting the needs of patients with ultra-rare diseases and in optimising the operational aspects of these clinical studies.